201 related articles for article (PubMed ID: 36239933)
21. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
[TBL] [Abstract][Full Text] [Related]
22. Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
Dar H; Johansson A; Nordenskjöld A; Iftimi A; Yau C; Perez-Tenorio G; Benz C; Nordenskjöld B; Stål O; Esserman LJ; Fornander T; Lindström LS
JAMA Netw Open; 2021 Jun; 4(6):e2114904. PubMed ID: 34190995
[TBL] [Abstract][Full Text] [Related]
23. Body weight correlates with mortality in early-stage breast cancer.
Enger SM; Greif JM; Polikoff J; Press M
Arch Surg; 2004 Sep; 139(9):954-58; discussion 958-60. PubMed ID: 15381612
[TBL] [Abstract][Full Text] [Related]
24. Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival.
Tarullo SE; Hill RC; Hansen KC; Behbod F; Borges VF; Nelson AC; Lyons TR
Oncogene; 2020 Mar; 39(13):2772-2785. PubMed ID: 32020054
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for breast cancer development by tumor characteristics among women with benign breast disease.
Figueroa JD; Gierach GL; Duggan MA; Fan S; Pfeiffer RM; Wang Y; Falk RT; Loudig O; Abubakar M; Ginsberg M; Kimes TM; Richert-Boe K; Glass AG; Rohan TE
Breast Cancer Res; 2021 Mar; 23(1):34. PubMed ID: 33736682
[TBL] [Abstract][Full Text] [Related]
26. Prognosis of premenopausal breast cancer and childbirth prior to diagnosis.
Phillips KA; Milne RL; Friedlander ML; Jenkins MA; McCredie MR; Giles GG; Hopper JL
J Clin Oncol; 2004 Feb; 22(4):699-705. PubMed ID: 14966094
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database.
Robinson TJ; Wilson LE; Marcom PK; Troester M; Lynch CF; Hernandez BY; Parrilla E; Brauer HA; Dinan MA
JAMA Netw Open; 2021 Oct; 4(10):e2131020. PubMed ID: 34714340
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Survival Outcomes Among Patients With Breast Cancer With Distant vs Ipsilateral Supraclavicular Lymph Node Metastases.
Pan H; Wang H; Qian M; Mao X; Shi G; Ma G; Yu M; Xie H; Ling L; Ding Q; Zhang K; Wang S; Zhou W
JAMA Netw Open; 2021 Mar; 4(3):e211809. PubMed ID: 33724394
[TBL] [Abstract][Full Text] [Related]
29. Neighborhood Disadvantage, African Genetic Ancestry, Cancer Subtype, and Mortality Among Breast Cancer Survivors.
Iyer HS; Zeinomar N; Omilian AR; Perlstein M; Davis MB; Omene CO; Pawlish K; Demissie K; Hong CC; Yao S; Ambrosone CB; Bandera EV; Qin B
JAMA Netw Open; 2023 Aug; 6(8):e2331295. PubMed ID: 37647068
[TBL] [Abstract][Full Text] [Related]
30. Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers.
Sieuwerts AM; Willis S; Burns MB; Look MP; Meijer-Van Gelder ME; Schlicker A; Heideman MR; Jacobs H; Wessels L; Leyland-Jones B; Gray KP; Foekens JA; Harris RS; Martens JW
Horm Cancer; 2014 Dec; 5(6):405-13. PubMed ID: 25123150
[TBL] [Abstract][Full Text] [Related]
31. Association of Neighborhood-Level Household Income With 21-Gene Recurrence Score and Survival Among Patients With Estrogen Receptor-Positive Breast Cancer.
Ma SJ; Gill J; Waldman O; Yendamuri K; Dunne-Jaffe C; Chatterjee U; Fekrmandi F; Shekher R; Iovoli A; Yao S; Oladeru OT; Singh AK
JAMA Netw Open; 2023 Feb; 6(2):e230179. PubMed ID: 36809469
[TBL] [Abstract][Full Text] [Related]
32. Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women.
Keegan TH; Press DJ; Tao L; DeRouen MC; Kurian AW; Clarke CA; Gomez SL
Breast Cancer Res; 2013; 15(5):R95. PubMed ID: 24131591
[TBL] [Abstract][Full Text] [Related]
33. Gestational diabetes and risk of breast cancer before age 55 years.
Bertrand KA; O'Brien KM; Wright LB; Palmer JR; Blot WJ; Eliassen AH; Rosenberg L; Sandin S; Tobias D; Weiderpass E; Zheng W; Swerdlow AJ; Schoemaker MJ; Nichols HB; Sandler DP
Int J Epidemiol; 2022 Jan; 50(6):1936-1947. PubMed ID: 34458915
[TBL] [Abstract][Full Text] [Related]
34. Prognosis of breast cancer is associated with one-carbon metabolism related nutrients among Korean women.
Lee Y; Lee SA; Choi JY; Song M; Sung H; Jeon S; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
Nutr J; 2012 Aug; 11():59. PubMed ID: 22929014
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
36. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.
Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Stefanick ML; Vitolins M; Kabat GC; Rohan TE; Li CI
J Natl Cancer Inst; 2011 Mar; 103(6):470-7. PubMed ID: 21346227
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer Database.
Cheng E; Blackburn HN; Ng K; Spiegelman D; Irwin ML; Ma X; Gross CP; Tabung FK; Giovannucci EL; Kunz PL; Llor X; Billingsley K; Meyerhardt JA; Ahuja N; Fuchs CS
JAMA Netw Open; 2021 Jun; 4(6):e2112539. PubMed ID: 34132794
[TBL] [Abstract][Full Text] [Related]
38. Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race.
Ren Y; Black DM; Mittendorf EA; Liu P; Li X; Du XL; He J; Yang J; Hunt KK; Yi M
PLoS One; 2014; 9(10):e110281. PubMed ID: 25333877
[TBL] [Abstract][Full Text] [Related]
39. Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis.
Holm J; Li J; Darabi H; Eklund M; Eriksson M; Humphreys K; Hall P; Czene K
J Clin Oncol; 2016 Jan; 34(3):251-8. PubMed ID: 26628467
[TBL] [Abstract][Full Text] [Related]
40. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
